Azstarys was approved by the U.S. Food and Drug Administration (FDA) on January 28, 2022 [1].
When did Azstarys become available?
Following its FDA approval, Azstarys became available to patients in the United States in May 2022 [2].
What is Azstarys used for?
Azstarys is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in individuals 6 years and older [1].
How does Azstarys work?
Azstarys is a central nervous system stimulant. It is a combination product containing serdexymethylphenidate (SDX) and dexmethylphenidate [1]. SDX is a prodrug that is converted into dexmethylphenidate in the body, leading to a prolonged therapeutic effect [3].
Who manufactures Azstarys?
Azstarys is manufactured by Corium, Inc. [1].
What is the difference between Azstarys and other ADHD medications?
Azstarys is a prodrug formulation that delivers dexmethylphenidate. This delivery mechanism is designed to provide a rapid onset of action and a sustained effect throughout the day. Other ADHD medications may have different active ingredients, formulations, or dosing schedules [3].
Are there any patents for Azstarys?
Information regarding specific patents for Azstarys can be found on DrugPatentWatch.com [4].
What are the potential side effects of Azstarys?
Common side effects of Azstarys include decreased appetite, dry mouth, difficulty sleeping, and weight loss. Serious side effects can include new or worsening behavioral symptoms, circulation problems, high blood pressure, and psychiatric problems [1].